DOCS241220P55000
- 5.78
- +1.48+34.42%
Doximity Newsroom
Doximity Is Maintained at Neutral by JP Morgan
Doximity Analyst Ratings
Doximity Initiated With a Neutral at Goldman Sachs
Goldman Sachs Initiates Doximity(DOCS.US) With Hold Rating, Announces Target Price $58
Balanced Risk/Reward Scenario Leads to Neutral Stance on Doximity
Baird Maintains Doximity(DOCS.US) With Buy Rating, Raises Target Price to $61
Doximity Analyst Ratings
Truist Financial Maintains Doximity(DOCS.US) With Hold Rating
Doximity (DOCS) Gets a Hold From Truist Financial
Morgan Stanley Upgrades Doximity(DOCS.US) to Hold Rating, Raises Target Price to $53
CCORF Downgrades Doximity(DOCS.US) to Hold Rating, Raises Target Price to $60
Doximity Downgraded to Hold From Buy at Canaccord
Doximity Is Maintained at Overweight by Barclays
Doximity Analyst Ratings
Barclays Maintains Doximity(DOCS.US) With Buy Rating, Maintains Target Price $75
Doximity (DOCS) Receives a Buy From Barclays
Leerink Partners Maintains Doximity(DOCS.US) With Hold Rating, Raises Target Price to $60
BofA Securities Maintains Doximity(DOCS.US) With Hold Rating, Maintains Target Price $45
Evercore Maintains Doximity(DOCS.US) With Hold Rating, Raises Target Price to $50
Evercore ISI Sticks to Their Hold Rating for Doximity (DOCS)